|
US2021072255A1
|
|
System and method for protein corona sensor array for early detection of diseases
|
|
WO2021076987A1
|
|
System and method for a tissue resection margin measurement device
|
|
WO2021072028A1
|
|
Activators of heme regulated inhibitor kinase (hri)
|
|
WO2021062366A1
|
|
Multimodal fusion for diagnosis, prognosis, and therapeutic response prediction
|
|
WO2021046521A1
|
|
Automated evaluation of quality assurance metrics for assisted reproduction procedures
|
|
WO2021046477A1
|
|
Systems and methods for assessing outcomes of the combination of predictive or descriptive data models
|
|
WO2021041747A1
|
|
Smart mattress system and methods for patient monitoring and repositioning
|
|
WO2021034895A1
|
|
Medical microdevice anchoring apparatus, installation and retrieval tools, and methods of using same
|
|
WO2021034889A1
|
|
Medical microdevice anchoring apparatus, installation and retrieval tools, and methods of using same
|
|
WO2021021706A1
|
|
Inhibitors of macrophage migration inhibitory factor
|
|
WO2021007551A1
|
|
Longevity signatures and their applications
|
|
WO2020257285A1
|
|
Materials and methods for generating functional oocytes
|
|
WO2020252453A1
|
|
Membrane attack complexes and uses thereof
|
|
WO2020247757A1
|
|
System and method for unbinding of plasma protein-bound active agents using an ultrasound system
|
|
WO2020242892A1
|
|
Gene therapy for alzheimer's disease
|
|
WO2020214798A1
|
|
Epigenetic signatures of alzheimer's disease
|
|
US2020318200A1
|
|
Methods for Identifying Progression of a Primary Melanoma
|
|
WO2020205729A1
|
|
Targeted synergistic cancer immunotherapy
|
|
WO2020198613A1
|
|
Inhibition of monoamine oxidase subtype a (maoa) mitigates cardiovascular calcification
|
|
WO2020191269A1
|
|
Robotic artificial intelligence nasal/oral/ rectal enteric tube
|
